 Company founder Robert Coates becomes Executive Chairman Houston, Texas--Newsfile Corp. - March 17, 2020 - Memgen, a private biotechnology company developing innovative immuno-oncology drugs, announced today that its Board of Directors has appointed Gregory B. Brown, MD, as Chief Executive Officer. He currently serves and will remain on the Memgen board of directors. The company also announced that Robert Coates, PhD, founder and prior Chief Executive Officer, will become Executive Chairman.Having seen the scientific capability ... 